Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Homie Razavi

8 ta ish

Center for Disease Analysis

AkademScholarda batafsil koʻrsatkichlar

  1. Viral hepatitis elimination challenges in low‐ and middle‐income countries—Uzbekistan Hepatitis Elimination Program (UHEP)

    Erkin Musabaev, Chris Estes, Shakhlo Sadirova +10

    MaqolaOchiq kirishHepatitis B Virus StudiesLiver International202310 iqtibos
    ABI

  2. Progress Toward Hepatitis B and Hepatitis C Elimination Using a Catalytic Funding Model — Tashkent, Uzbekistan, December 6, 2019–March 15, 2020

    Rick Dunn, Erkin Musabaev, Homie Razavi +7

    MaqolaOchiq kirish20209 iqtibos
    ABI

  3. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

    Chris Estes, Homie Razavi, Rohit Loomba +2

    Sharh maqolaOchiq kirish20173 iqtibos
    ABI

  4. Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission – Authors' reply

    Devin Razavi‐Shearer, Homie Razavi

    Boshqa20182 iqtibos
    ABI

  5. Global epidemiology and genotype distribution of the hepatitis C virus infection

    E. Gower, Chris Estes, Sarah Blach +2

    Sharh maqola20142 iqtibos
    ABI

  6. The case for testing and treating all HBV patients

    Homie Razavi, Shakhlo Sadirova, Shokhista Bakieva +3

    Maqola20200 iqtibos
    ABI

  7. The global NAFLD policy review and preparedness index: Are countries ready to address this silent public health challenge?

    Jeffrey V. Lazarus, Henry E. Mark, M Villota-Rivas +97

    MaqolaOchiq kirish20210 iqtibos
    ABI

  8. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

    Homie Razavi, Imam Waked, Huma Qureshi +97

    MaqolaOchiq kirishHepatitis C virus researchJournal of Hepatology20250 iqtibos
    ABI